Some postmenopausal women with breast cancer may forgo chemotherapy

SEMrush
Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.
[automaticbacklinks]